menu
close_24px
Clinical Trial Registry

Invest in Hemostemix and be a part of the Future of Stem Cell Therapy 

We are dedicated to advancing the science of ACP-01 and creating opportunities to change the therapeutic landscape.

Interested in hearing about news and events?  Subscribe Here

 

Investor Presentations

Annual General Meeting Materials

2025

2023/2024 Consolidated Financial Statements 

SIDAR Proxy  


Financial Statements Request Form  

Notice of Annual and Special Meeting of Shareholders  

2024

2022/2023 Consolidated Financial Statements  

 

2023

2021/2022 Consolidated Financial Statements  

Notice of Annual and Special Meeting of Shareholders  

2022

2020/2021 Consolidated Financial Statements 

 

Comp-1

The Addressable Market - what issues the patients face

The global CLTI market was valued at $4.02Billion in 2022. The Ischemic Heart Disease (IHD)drugs market reached US $6.1 Billion in 2022

final-1
final-3
final-4